Skip to content
Government ACT, Medical Health Aged Care

Pharmacists win expanded scope

Pharmaceutical Society of Australia (PSA) 2 mins read

The Pharmaceutical Society of Australia’s (PSA) campaign to expand scope of practice for pharmacists paid off this week, with new authorisations announced by the ACT Government.

Under yesterday’s legislative update, pharmacists in the ACT are authorised to administer medicines for injection, including Long-Acting Injectable Buprenorphine (LAIB).

The PSA’s ACT Branch President Olivia Collenette said the landmark change, which would enhance patient access to vital injectable medications, came after a lot of campaigning.

“We have long championed expansion of pharmacist scope of practice and, while there is still a long way to go, this is a significant step,” she said.

“We are thrilled that our advocacy on this particular issue has borne fruit, signalling a brighter future for pharmacy and reinforcing our commitment to advancing patient-centred care.”

The PSA has already provided comprehensive training on administering medicines by injection.

Pharmacists are encouraged to access these resources to ensure they are equipped with the necessary knowledge and skills to provide optimal care.

“PSA encourages all pharmacists in the ACT to familiarise themselves with the updated regulations and embrace this progressive expansion of their professional capabilities,” Ms Collenette said.

“By staying informed and ensuring adherence to best practices, pharmacists will continue to play a pivotal role in enhancing patient outcomes and promoting public health.”

For more information on the administration of medicines for injection by pharmacists in the ACT, visit:

Pharmacist Vaccinations and Injectables | Health (act.gov.au)

 

 

Media contact:   Dave Westman   M: 0480 099 798      E: david.westman@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Finance Investment, Government ACT
  • 13/06/2024
  • 10:42
Chartered Accountants ANZ

CA ANZ STATEMENT ON SENATE INQUIRY INTO THE MANAGEMENT AND ASSURANCE OF INTEGRITY BY CONSULTING SERVICES

Chartered Accountants Australia and New Zealand (CA ANZ) notes yesterday’s recommendations from the Senate inquiry into the management and assurance of integrity by consulting services. CA ANZ CEO, Ainslie van Onselen, said the close relationship between professionals who are ‘consultants’ and ‘accountants’ is why CA ANZ played an active role in this inquiry. Ms van Onselen said the accounting body is pleased to see a call for the Department of Finance Supplier Code of Conduct to incorporate elements of APES 110 - the Code of Ethics for Professional Accountants (Recommendation 5). “The accountancy profession is the world's only profession subscribing…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 13/06/2024
  • 10:42
Firebrick Pharma

Firebrick Pharma (ASX:FRE) launches Nasodine in Singapore

Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is proud to announce that itsproduct, Nasodine® Nasal Spray (“Nasodine”), is now available for sale in Singapore. Customers will be able to order the product through Firebrick’s new website dedicated tosupport Singapore sales: www.nasodine-sg.com In Singapore,Nasodine is classified as a topical antiseptic and does not require approval orlicensing by Singapore’s Heath Sciences Authority (HSA) before sale. However, anyadvertisements to Singapore consumers need prior approval by the HSA. Firebrick receivedapproval from the HSA for its consumer advertisements on 12 June 2024. Nasodine will be the first PVP-I nasal spray available in the region and therefore…

  • Contains:
  • International News, Medical Health Aged Care
  • 13/06/2024
  • 10:12
Charles Darwin University

CDU EXPERT: It’s getting hot in here – we need to learn to live with it

13 JUNE, 2024 Who: Charles Darwin University heat stress expert Dr Sarah Carter. Dr Carter is a member of the Heat and Health Research Incubator group, and has been part of the team implementing the Australian Open heat stress scales. Topics: The impact of heatwaves on the human body, following recent heatwaves in Delhi and Athens. How to manage and adapt to heat stress. Internal and external factors contributing to heat stress. Contact details: Call +61 8 8946 6721 or email media@cdu.edu.au to arrange an interview. Quotes attributable to Dr Sarah Carter: "Heatwaves provide significant stress to our systems by…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.